Lilly (Eli) & Co (NYSE:LLY) on 12/19/2018 declared a dividend of $ 0.6450 per share payable on March 08, 2019 to shareholders of record as of February 15, 2019. Dividend amount recorded is an increase of $ 0.0825 from last dividend Paid.

Lilly (Eli) & Co (NYSE:LLY) has paid dividends since 1885, has a current dividend yield of 2.4225351810% and has increased its dividends for 3 successive years.

Lilly (Eli) & Co's market cap is $ 112,817,793,000 and has a PE ratio of 226.60. The stock price closed yesterday at $ 106.50 and has a 52 week low/high of $ 73.69 and $ 119.84.

Eli Lilly & Company is engaged in discovering, developing, manufacturing, and marketing products in two business segments: human pharmaceutical products and animal health products. Co.'s human pharmaceutical products include: endocrinology, neuroscience, oncology, immunology, and cardiovascular. Co.'s animal health products are comprised of products for animals, among others, which include Rumensin®, a cattle feed additive, and Tylan®, an antibiotic used to control certain diseases in cattle, swine, and poultry; as well as products for companion animals, which include Trifexis® and Comfortis®, a chewable tablet that kills fleas and prevents flea infestations on dogs.

For more information on Lilly (Eli) & Co click here.